These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30721384)

  • 1. Moving forward the in vivo diagnosis of the synucleinopathies.
    Vilas D
    Clin Auton Res; 2019 Dec; 29(6):575-576. PubMed ID: 30721384
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.
    Leys F; Wenning GK; Fanciulli A
    Neurol Sci; 2022 Jan; 43(1):187-198. PubMed ID: 34817726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synuclein-One study: skin biopsy detection of phosphorylated α-synuclein for diagnosis of synucleinopathies.
    Gibbons CH; Freeman R; Bellaire B; Adler CH; Moore D; Levine T
    Biomark Med; 2022 May; 16(7):499-509. PubMed ID: 35272481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synucleinopathies.
    Lamotte G; Singer W
    Handb Clin Neurol; 2023; 196():175-202. PubMed ID: 37620069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration.
    Wales P; Pinho R; Lázaro DF; Outeiro TF
    J Parkinsons Dis; 2013; 3(4):415-59. PubMed ID: 24270242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study.
    Donadio V; Incensi A; El-Agnaf O; Rizzo G; Vaikath N; Del Sorbo F; Scaglione C; Capellari S; Elia A; Stanzani Maserati M; Pantieri R; Liguori R
    Sci Rep; 2018 Sep; 8(1):14246. PubMed ID: 30250046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential prognostic role of cardiovascular autonomic failure in α-synucleinopathies.
    Fanciulli A; Strano S; Colosimo C; Caltagirone C; Spalletta G; Pontieri FE
    Eur J Neurol; 2013 Feb; 20(2):231-5. PubMed ID: 22834919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in synucleinopathies: A prospective cohort study.
    Goldstein DS; Holmes C; Sharabi Y; Wu T
    Neurology; 2015 Nov; 85(18):1554-61. PubMed ID: 26432848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson's Disease.
    Doppler K
    J Parkinsons Dis; 2021; 11(3):937-947. PubMed ID: 33814464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin nerve α-synuclein deposits in Parkinson's disease and other synucleinopathies: a review.
    Donadio V
    Clin Auton Res; 2019 Dec; 29(6):577-585. PubMed ID: 30506233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure Autonomic Failure.
    Thaisetthawatkul P
    Curr Neurol Neurosci Rep; 2016 Aug; 16(8):74. PubMed ID: 27338613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis.
    Sako W; Murakami N; Izumi Y; Kaji R
    Mov Disord; 2014 Nov; 29(13):1599-605. PubMed ID: 25258345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Passive Immunotherapies for Synucleinopathies.
    Bergström AL; Kallunki P; Fog K
    Mov Disord; 2016 Feb; 31(2):203-13. PubMed ID: 26704735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure autonomic failure and the differential diagnosis of autonomic peripheral neuropathies.
    González-Duarte A; Varma-Doyle A; Freeman R
    Curr Opin Neurol; 2021 Oct; 34(5):675-682. PubMed ID: 34392300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can skin biopsy differentiate Parkinson disease from multiple system atrophy? And other updates on recent autonomic research.
    Miglis MG; Muppidi S
    Clin Auton Res; 2020 Aug; 30(4):287-289. PubMed ID: 32648015
    [No Abstract]   [Full Text] [Related]  

  • 16. A Longitudinal Skin Biopsy Study of Phosphorylated Alpha-Synuclein in a Patient With Parkinson Disease and Orthostatic Hypotension.
    Infante R; Scaglione C; Incensi A; Rizzo G; Liguori R; Donadio V
    J Neuropathol Exp Neurol; 2020 Jul; 79(7):813-816. PubMed ID: 32529258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression in alpha-synucleinopathies: prevalence, pathophysiology and treatment.
    Stefanova N; Seppi K; Scherfler C; Puschban Z; Wenning GK
    J Neural Transm Suppl; 2000; (60):335-43. PubMed ID: 11205151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-Based α-Synuclein Seeding-A New Era for Identifying Parkinsonian Syndromes.
    Borsche M; Berg D
    Mov Disord; 2023 Aug; 38(8):1397-1398. PubMed ID: 37489601
    [No Abstract]   [Full Text] [Related]  

  • 19. Synucleinopathies.
    Coon EA; Singer W
    Continuum (Minneap Minn); 2020 Feb; 26(1):72-92. PubMed ID: 31996623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active immunization therapies for Parkinson's disease and multiple system atrophy.
    Schneeberger A; Tierney L; Mandler M
    Mov Disord; 2016 Feb; 31(2):214-24. PubMed ID: 26260853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.